I have had PSA tests annually for 10 years and in Oct 2023 had an elevated 6.42 result. Was referred to a urologist, whom performed a DRE. There was prostate enlargement but no tumor discovered through DRE. After discussing several options, I decided to have a biopsy on Nov 21, 2023.
Dec 5, 2023, I met with my urologist to discuss the findings.
12 core biopsy found 1 of 12 core positive for cancer. The path report was Acinar adenocarcinoma, Gleason score 3+4 = 7, grade group 2, 5/15 mm, 33%
Percentage of pattern 4 is approximately 10% Cribriform pattern 4 is absent.
Staging is T1c
Among the treatment options was AS, RP, and RT.
Feeling that AS was a risk without further data, I asked about adding genomic testing for another piece of data. The urologist submitted for Onco DX genomic testing and the result was a GPS of 60% intermediate high risk. I felt AS was off the table.
I had another PSA on January 19, 2024 and post biopsy was elevated to 9.32.
With the above info, I’m swimming in a sea of uncertainty.
The RO is recommending EBRT with possible ADT due to the genomic data. I have met with 2 RO’s, one wants fiducial markers and one doesn’t.
My Urologist feels confident that either RT or RP will be sufficient for a high cure rate.
The first RO did order a CT scan with contrast. The results were mostly unremarkable, sans a known hernia.
I have waffled between RT and RP mainly because no guarantee that if I have the RP that RT or ADT won’t still be in play at some point. I know that my Urologist has performed many RP’s.
Was leaning toward RP but RT is looking more positive as a first treatment option.. Hopefully I can get some fellow prostate cancer warriors to weigh in on their outlook.
Thanks in advance for taking the time to read this .🙂☮️